Exfoliative Dermatitis as a Para-neoplastic Syndrome of Prostate Adenocarcinoma: A Rare Case Report With Literature Review.

Autor:	Ghafouri SR; Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Escriba-Omar A; Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Wahdatyar I; Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Whited N; Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Hakim MN; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Gaur S; Department of Haematology and Oncology, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A., Dihowm F; Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, U.S.A.
Jazyk:	angličtina
Zdroj:	Cancer diagnosis & prognosis [Cancer Diagn Progn] 2021 Jul 03; Vol. 1 (4), pp. 289-295. Date of Electronic Publication: 2021 Jul 03 (Print Publication: 2021).
DOI:	10.21873/cdp.10038
Abstrakt:	Background/aim: This study aimed to report a rare case of erythroderma or exfoliative dermatitis as a paraneoplastic syndrome of prostate adenocarcinoma. Exfoliative dermatitis is a rare inflammatory skin condition that is characterized by desquamation and erythema involving more than 90% of the body surface area. It is a clinical manifestation and usually associated with various underlying cutaneous disorders, drug induced reactions and malignancies. Case Report: Herein we report a case of 55-year-old male patient who presented with progressively diffuse scaling and erythematous rash of 3 months duration. He was diagnosed with untreated prostate adenocarcinoma about 2 months prior his admission. Skin biopsy confirmed exfoliative erythroderma diagnosis. He was investigated extensively for other pathologies, however all work up remained negative except a CT finding of large heterogeneous prostate gland with elevated PSA which was consistent with prostate cancer. Daily oral prednisone for one week and hydrocortisone cream provided partial clinical improvement. The patient was discharged on tapering steroid to follow-up with urology and oncology for further underlying prostate carcinoma management. Conclusion: We concluded that the ongoing erythroderma was a paraneoplastic syndrome of prostate adenocarcinoma. Hence, early detailed history and routine screening of malignancy-related biomarkers is warranted on any individuals presenting with such symptoms. Competing Interests: None of the Authors have any financial or personal bias to declare. The Authors report no conflicts of interest. (Copyright 2021, International Institute of Anticancer Research.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu